Parallel Advisors, LLC Relay Therapeutics, Inc. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$6.01 - $11.48 $486 - $929	-81 Reduced 85.26%	14 $0
Q2 2023 May 20, 2024	BUY	$9.99 - $18.27 $809 - $1,479	81 Added 578.57%	95 $1,000
Q2 2023 Aug 04, 2023	BUY	$9.99 - $18.27 $949 - $1,735	95 New	95 $1,000
Q2 2022 Aug 01, 2022	BUY	$13.31 - $34.88 $159 - $418	12 New	12 $0
Q1 2022 Apr 28, 2022	SELL	$20.26 - $32.36 $1,438 - $2,297	-71 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$26.0 - $37.03 $1,846 - $2,629	71 New	71 $2,000

203

156M

207K

40K

Ticker RLAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 120,219,000
Market Cap $577M
Description
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.